Skip to main content
. 2017 Nov 9;7:15208. doi: 10.1038/s41598-017-15207-w

Figure 2.

Figure 2

PI3K inhibitor treatment inhibits AAA formation and progression. Male SD rats were administrated with intraperitoneal injection of Wortmannin at a dose of 0.5 mg/kg/day (dissolved in DMSO) from day 0 to day 28 after PPE infusion. AAAs diameter for each rat was measured directly underwent laparotomy. (A) Representative images of aorta from Wortmannin treatment or Vehicle treatment in rats at day 0 and day 28. (B) Aortic diameters in rats after PPE infusion treated with Wortmannin (n = 12) or Vehicle (n = 9), ANOVA followed by Newman-Keuls post-test, *P < 0.05 and ** P < 0.01 vs vehicle group. (C) The incidence of AAA in PPE-infused rats with Wortmannin or Vehicle treatment was evaluated. Kaplan-Meier analysis. *P < 0.05 vs vehicle group. (D,E) Histological staining of EVG or Masson was performed to evaluate the development of AAAs. Representative aortic histology images for elastin and SMCs in each group. Medial elastin fragmentation and SMCs destruction were scored as mild 1 to severe 5 using a histology grading system. Data are presented with Mean and SD, n = 9–12 in each group. Nonparametric Mann-Whitney test. * P < 0.05 vs vehicle group.